Profil
Chloe Herpain formerly worked at Hunza Management SARL, as Business Analyst from 2011 to 2012.
Anciens postes connus de Chloe Herpain
| Sociétés | Poste | Fin |
|---|---|---|
Hunza Management SARL
Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Analyste en capital-investissement | 01/12/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hunza Management SARL
Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Finance |
















